Phosphodiesterase inhibitors as antiplatelet agents in vascular surgery.
Kambayashi
J
J
Second Department of Surgery, Osaka University Medical School, Japan.
Watase
M
M
Kawasaki
T
T
Shiba
E
E
Sakon
M
M
Mori
T
T
Isaka
Y
Y
Kimura
K
K
Kamada
T
T
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000818:Animals; D000077407:Cilostazol; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D011817:Rabbits; D013777:Tetrazoles / Q000494:pharmacology*; D014656:Vascular Surgical Procedures
D010726:Phosphodiesterase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; D013777:Tetrazoles; C049662:1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000077407:Cilostazol